Valproate is a commonly prescribed anticonvulsant drug. It has a potential to cause hyperammonemia even in the presence of normal liver function tests. This hyperammonemic state can lead to encephalopathy referred as Valproate induced hyperammonemic encephalopathy (VHE). Here we present a case of valproate induced hyperammonemic encephalopathy in a young male caused by initiation of valproate therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.55519/JAMC-04-S4-10190 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!